Menu
Dear Editor: There is no doubt now that the use of botulinum toxin (BoNT) in aesthetics has been a revolution for the noninvasive treatment of patients. In the last several decades, the use of BoNT has changed from fixed doses delivered at fixed time intervals into fixed anatomical sites, all of which were required for
J Clin Aesthet Dermatol. 2021;14(1):14–20. by Clinton W. Enos, MD; Soquel Rey, BS; Jayne Slocum, BS; Lauren Green, MPH; and Edward Prodanovic, MD Dr. Enos, Dr. Prodanovic, Mr. Rey, and Ms. Slocum are with the Department of Dermatology, Eastern Virginia Medical School in Norfolk, Virginia. Ms. Green is with the Healthcare Analytics and Delivery Science
J Clin Aesthet Dermatol. 2021;14(1):21–23 by Stephen Ansah-Addo, MD, and Andrew F. Alexis, MD, MPH Mr. Ansah-Addo is with the Albert Einstein College of Medicine in the Bronx, New York, New York. Dr. Alexis is with the Department of Dermatology at Mount Sinai St. Luke’s and Mount Sinai West in New York, New York. FUNDING:
J Clin Aesthet Dermatol. 2021;14(1):24–26. by Bruna Souza Felix Bravo, MD; Camila Roos Mariano da Rocha, MD; Leonardo Gonçalves Bravo, MD; Raquel de Melo Carvalho, MD; and Lucia Joffily, MD Drs. B. S. F. Bravo, Mariano Da Rocha, L. G. Bravo, and De Melo Carvalho are Clínica Bravo in Rio de Janeiro, Brazil. Dr. Joffily
J Clin Aesthet Dermatol. 2021;14(1):27–29. by Hassie Cooper, DO; Maheera Farsi, DO, FAAD; and Richard Miller, DO, FAOCD All authors are with Largo Medical Center in Largo, Florida. FUNDING: No funding was provided for this article. DISCLOSURES: The authors report no conflicts of interest relevant to the content of this article. ABSTRACT: Primary mucosal melanomas
